Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Carlton C. Barnett

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5686-8357; OpenAlex author ID A5052364272. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 3

  1. Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC. Co-author DOI 10.1177/1457496919900413↗
  2. Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma. Last author DOI 10.1152/ajpregu.00320.2011↗
  3. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy. Co-author DOI 10.1158/1078-0432.ccr-10-1983↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Atsushi Oba · 1 shared paper, 2020 · strength 0.13
  2. Quoc Riccardo Bao · 1 shared paper, 2020 · strength 0.13
  3. Marco Del Chiaro · 1 shared paper, 2020 · strength 0.13
  4. Richard David Schulick · 1 shared paper, 2020 · strength 0.13
  5. Douglas D. Benson · 1 shared paper, 2012 · strength 0.03
  6. Long Shan Li · 1 shared paper, 2011 · strength 0.02
  7. David A. Boothman · 1 shared paper, 2011 · strength 0.02
  8. Rolf A. Brekken · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.